about
Identification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activityStorage of Blood Components Does Not Decrease Haemostatic Potential: In vitro Assessment of Fresh versus Stored Blood Components Using ThromboelastographySpecific and global coagulation tests in patients with mild haemophilia A with a double mutation (Glu113Asp, Arg593Cys).Monitoring rFVIII prophylaxis dosing using global haemostasis assays.Exploring the biological basis of haemophilic joint disease: experimental studies.Towards standardization of clot waveform analysis and recommendations for its clinical applications.The utility of thromboelastography in inherited and acquired bleeding disorders.Anti-factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation.New quantitative aPTT waveform analysis and its application in laboratory management of haemophilia A patients.Pharmacokinetic and pharmacodynamic properties of plasma-derived vs. recombinant factor IX in patients with hemophilia B: a prospective crossover study.Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system.Clot waveform analysis: Where do we stand in 2017?Global haemostasis and point of care testing.A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model.
P2860
Q28487387-4E80DDDA-23E4-4436-9DA9-16E37448F457Q34625437-4CDD0285-E5B4-4CB8-A73B-63C40AD90FA7Q36220085-2AE9CBAE-E911-498A-BC92-DFB06F632C8EQ36788113-B77084AE-E798-4DA4-BD91-6772E1394C33Q37951686-C32E74CC-0342-4799-88B9-9B0BBECA5C37Q38104482-D879A414-29D4-4781-90DC-ACED3B3CDC7CQ38855599-D3625003-B0F9-48D2-B57B-2E9E6F0DCABEQ45864199-D7F5E849-D09E-455B-8DA5-7844DD5C1043Q45869012-7B0478F0-B267-4059-A32B-4A4AB8EBB76CQ45869388-2C7384D8-5938-4BF0-9285-C5065C147222Q45870104-9238E925-0B3B-4691-A2EC-77FF45D2E4E0Q45871576-C6C1F68C-9B89-4C4C-9490-C7E8583B6A01Q45871584-A0E92015-3F26-4D2F-BD3C-B82D0A7DA82DQ45879939-8B191BB9-1364-4644-BE57-3984F387057FQ45882197-D2E2B236-36BC-4CEB-90D1-50B3035BB4E0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New assays for monitoring haemophilia treatment.
@en
New assays for monitoring haemophilia treatment.
@nl
type
label
New assays for monitoring haemophilia treatment.
@en
New assays for monitoring haemophilia treatment.
@nl
prefLabel
New assays for monitoring haemophilia treatment.
@en
New assays for monitoring haemophilia treatment.
@nl
P2093
P2860
P1433
P1476
New assays for monitoring haemophilia treatment.
@en
P2093
P2860
P356
10.1111/J.1365-2516.2008.01737.X
P478
14 Suppl 3
P577
2008-07-01T00:00:00Z